RESULTS OF CLINICAL TRIALS OF THE SAFETY AND EFFICACY OF THE FIRST RUSSIAN BOTULOTOXINUM TYPE A RELATOX® IN THE CORRECTION OF MIMIC WRINKLES

Номер журнала: 
6
Год издания: 
2011

Professor V.D. Elkin, MD2; N.V. Kupina, Cand. Med. Sci.1;
E.V. Plotnikova2, D.V. Timonenkov1, D.S. Bushmenkov1, A.A. Tsaan1 THE FIRST RUSSIAN BOTULOTOXINUM TYPE A RELATOX® IN THE CORRECTION OF MIMIC WRINKLES
Professor V.D. Elkin, MD2; N.V. Kupina, Cand. Med. Sci.1;
E.V. Plotnikova2, D.V. Timonenkov1, D.S. Bushmenkov1, A.A. Tsaan1
1Mikrogen Research-and-Production Association, Moscow;
2Acad. E.A. Vagner Perm State Medical Academy

The paper gives the results of comparative clinical trials of the Russian botulotoxinum type A Relatox® and Botox® (Allergan, USA) in the correction of mimic wrinkles. The safety and therapeutic efficacy of the agents have proven comparable.

Key words: mimic wrinkles
Relatox®
Botox®
safety
efficacy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.